Form 4: Bank of America Entities Reduce Bluejay Diagnostics Stake

Bank of America entities, including Bank of America Corp., Bank of America N.A., and BofA Securities, Inc., have jointly filed a Form 4 indicating their beneficial ownership of Bluejay Diagnostics, Inc. (BJDX) has fallen below the 10% threshold, no longer subjecting them to Section 16 reporting requirements.

Summary

• Bank of America Corporation, Bank of America N.A., and BofA Securities, Inc. have filed a Form 4 statement.
• This filing indicates that their beneficial ownership in Bluejay Diagnostics, Inc. (BJDX) has decreased to below 10%.
• As a result, these entities are no longer subject to the reporting requirements under Section 16 of the Securities Exchange Act of 1934.
• The earliest transaction date noted in the filing is July 8, 2026.
• The joint filing agreement confirms their intent to file jointly for any required Section 13 or Section 16 filings.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily concerns reporting obligations rather than significant operational or financial performance changes for Bluejay Diagnostics.

Positives

• Bank of America entities are no longer required to file under Section 16, simplifying their reporting obligations.
• The decrease in ownership suggests a potential strategic shift or reallocation of assets by Bank of America.

Negatives

• The filing does not specify the exact amount of securities disposed of, only that ownership fell below 10%.

Risks

• The filing does not explicitly mention any risks.
• A decrease in beneficial ownership by a major financial institution could be perceived negatively by the market, although the reasons are not stated.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future transactions or ownership levels.

Management Comments

• Bank of America, BANA and BOFAS are submitting this form to indicate they are no longer subject to Section 16 as their beneficial ownership has decreased below 10 percent.

Industry Context

StockSavvy.ai notes that a Form 4 filing by major financial institutions like Bank of America often signals a rebalancing of investment portfolios or a strategic decision to reduce exposure to a particular company, which can be a signal to other market participants.

Corporate Governance

Stakeholder Impact

• Shareholders of Bluejay Diagnostics, Inc. may note the reduction in ownership by Bank of America entities, which could influence market perception, though the reasons are not detailed.
• Creditors and suppliers of Bluejay Diagnostics, Inc. are unlikely to be directly impacted by this reporting change, as it does not reflect on the company's operational or financial health.

Next Steps

• The Bank of America entities will no longer be subject to Section 16 reporting requirements for Bluejay Diagnostics, Inc.

Key Dates

Keywords

Form 4, SEC Filing, Beneficial Ownership, Section 16, Bluejay Diagnostics, BJDX, Bank of America, BofA Securities, Insider Trading, Ownership Threshold